logo

For the Inventor, By the Inventor

Horng-Jyh Harn

Taipei, Taiwan

Horng-Jyh Harn

This inventor holds 32 USPTO granted patents and 20 published patent applications and 13 EPO patents, primarily in Stem Cell Therapy. Top assignees: Everfront Biotech Inc., Gwo Xi Stem Cell Applied Technology Co., Ltd., China Medical University. Active years: 2008-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Horng-Jyh Harn. Retrieved from https://idiyas.com/inventor/horng-jyh-harn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 32 

% Patents Active = 90.6

 

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 19(Granted Patents)


Location History:

  • Banchiau, TW (2011)
  • Taipei, TW (2008 - 2020)
  • Hsinchu County, TW (2018 - 2020)
  • Zhubei, TW (2016 - 2021)
  • Taichung, TW (2014 - 2022)
  • New Taipei, TW (2012 - 2024)
  • Hualien, TW (2024)

Company Filing History:

goldMedal8 out of 9 
 
Everfront Biotech Inc.
 patents
silverMedal7 out of 11 
 
Gwo Xi Stem Cell Applied Technology Co., Ltd.
 patents
bronzeMedal6 out of 110 
 
China Medical University
 patents
4. 3 out of 12 
 
National Dong Hwa University
 patents
5. 2 out of 3 
 
Buddhist Tzu Chi General Hospital
 patents
6. 1 out of 10 
 
Buddhist Tzu Chi Medical Foundation
 patents
7. 1 out of 1 
 
Ejia Biotechnology Co., Ltd.
 patent
8. 1 out of 1 
 
Hawking Biological Technology Co., Ltd.
 patent
9. 1 out of 9,308 
 
Industrial Technology Research Institute
 patents
10. 1 out of 4 
 
Taiwan Mitochondrion Applied Technology
 patents
11. 1 out of 9 
 
Taiwan Mitochondrion Applied Technology Co., Ltd.
 patents
12. 1 out of 3 
 
Tzu Chi Buddhist General Hospital
 patents
where one patent can have more than one assignee

Years Active: 2008-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Phthalide Compounds
Meningioma Treatment
Amyotrophic Lateral Sclerosis
Stem Cell Extracts
Cancer Formulation
Neuroprotection
Motor Neuron Progenitor Cells
Pulmonary Fibrosis
Autoimmune Diseases
Hepatic Progenitor Cells
32 patents (USPTO):Explore Patents
1. 12740964 - Use of phthalide compounds in treatment of meningioma (2026-09-22),
2. 11963969 - Method for prevention or treatment of amyotrophic lateral sclerosis by administering gastrodin (2024-04-23),
3. 11920157 - Applications of butylidenephthalide (2024-03-05),
4. 11345888 - Method and pharmaceutical composition for continuously maintaining growth of a motor neuron progenitor cell (2022-05-31),
5. 11020358 - Method for the anti-senescence of and/or rejuvenating stem cells (2021-06-01),
6. 11013716 - Method for providing an increased expression of telomerase, brain-derived neurotrophic factor, stromal cell-derived factor-1, CXC chemokine receptor 4, and/or immune regulatory factor of stem cell (2021-05-25),
7. 10987339 - Uses of butylidenephthalide (2021-04-27),
8. 10688128 - Use of Z-butylidenephthalide in activating autoimmune system (2020-06-23),
9. 10682335 - Use of butylidenephthalide (Bdph), method of using the same, and method for preparing pharmaceutical composition containing the same (2020-06-16),
10. 10639264 - Mesenchymal stem cell extract and its use (2020-05-05),
11. 10543191 - Use of butylidenephthalide (Bdph), method of using the same, and method for preparing pharmaceutical composition containing the same (2020-01-28),
12. 10493105 - Isolated adipose-derived mesenchymal stem cells treated with angelica extract or butylidenephthalide, and wherein the cells have an increased mitochondrial membrane potential and a decreased level of IL-8, and methods for treating parkinson's disease (2019-12-03),
13. 10463645 - Method for delaying the onset of pulmonary fibrosis or treating pulmonary fibrosis (2019-11-05),
14. 10441566 - Use of butylidenephthalide (2019-10-15),
15. 10022313 - Mesenchymal stem cell extract and its use (2018-07-17),

Title: Horng-Jyh Harn: Pioneering Innovations in Medical Science

Introduction:

Horng-Jyh Harn, a visionary inventor based in New Taipei, Taiwan, has made significant contributions to the field of medical science through his relentless pursuit of innovation. With a total of 30 patents to his name, Harn has gained recognition for his groundbreaking work in creating impactful solutions that have the potential to revolutionize healthcare technologies.

Latest Patents:

Among his latest patents is the groundbreaking work on the Applications of butylidenephthalide (BP). This includes developing a kit for promoting differentiation of stem cells into brown adipose cells and preparing a medicament for inhibiting the accumulation of white adipose cells. Additionally, Harn has introduced a method and pharmaceutical composition for continuously maintaining the growth of motor neuron progenitor cells. These inventions showcase his commitment to advancing medical science through cutting-edge research and development.

Career Highlights:

Harn has made significant strides in his career, working with reputable companies such as Gwo Xi Stem Cell Applied Technology Co., Ltd., and Everfront Biotech Inc. His innovative solutions have not only garnered attention within the industry but have also laid the foundation for potential breakthroughs in the treatment of various medical conditions related to damaged motor neurons.

Collaborations:

Throughout his career, Harn has collaborated with esteemed professionals in the field, including Shinn-Zong Lin and Tzyy-Wen Chiou. These collaborations have fostered a culture of knowledge-sharing and innovation, leading to the development of novel technologies that have the potential to transform the healthcare landscape.

Conclusion:

Horng-Jyh Harn's unwavering dedication to innovation and his groundbreaking inventions in medical science have solidified his reputation as a visionary inventor in New Taipei and beyond. His work continues to inspire and drive advancements in the field, promising a future where his inventions may one day redefine the standard of medical care worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…